Comment on "Terlipressin in chronic hyperdynamic endotoxic shock: is it safe?" by P. Asfar
暂无分享,去创建一个
[1] P. Asfar. Terlipressin in chronic hyperdynamic endotoxic shock: is it safe? , 2003, Intensive Care Medicine.
[2] M. Singer,et al. Terlipressin for norepinephrine-resistant septic shock , 2002, The Lancet.
[3] Haruhiko Yamada,et al. Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock , 2001, Critical care medicine.
[4] P. Coriat,et al. Treatment of intraoperative refractory hypotension with terlipressin in patients chronically treated with an antagonist of the renin-angiotensin system. , 1999, Anesthesia and analgesia.
[5] H. Bruining,et al. Vasopressin deficiency contributes to the vasodilation of septic shock. , 1998, Circulation.
[6] I. Pávó,et al. Aggressive role of vasopressin in development of different gastric lesions in rats. , 1994, European journal of pharmacology.
[7] S. Vatner,et al. Effects of angiotensin, vasopressin, and methoxamine on cardiac function and blood flow distribution in conscious dogs. , 1976, The American journal of physiology.
[8] S. Rittig,et al. The hemodynamic effects of triglycyl‐lysine‐vasopressin (glypressin) in patients with parkinsonism and orthostatic hypotension , 1991, Movement disorders : official journal of the Movement Disorder Society.
[9] C. F. Schaefer,et al. Evaluation of cardiac output, total peripheral vascular resistance, and plasma concentrations of vasopressin in the conscious, unrestrained rat during endotoxemia. , 1985, Circulatory shock.